[ad_1]
The UN agency for the fight against AIDS welcomed on Monday 9 November the results of an antiretroviral, cabotegravir, which injected every two months helps protect women from the AIDS virus. “A study shows that injections are 89% more effective in preventing HIV than pre-exposure prophylaxis (PrEP) pills taken dailyThe agency said in a press release.
“These results are extremely important. UNAIDS has long called for further HIV prevention that is acceptable and effective for women and this could change the rules of the gameSays Winnie Byanyima, UNAIDS executive director. “If donors and countries invest in distributing injectable PrEP to women at higher risk of HIV infection, new infections could be drastically reduced.He stressed.
According to UNAIDS, the clinical trial involved 3,200 high-risk women between the ages of 18 and 45 in Botswana, Kenya, Malawi, South Africa, Eswatin, Uganda and Zimbabwe. The trial was stopped early because the data clearly showed the superiority of the injections over the daily ingestion of a pill. Four HIV infections occurred among the women who received the injections compared with 34 among those who took the pill. “The risk of HIV infection was nine times lower with cabotegravir than with the daily pill», Underlines the press release.
UNAIDS sees these injections as an alternative to taking a daily tablet, using a condom or abstaining. “The development of alternative methods to prevent HIV infection and less restrictive methods than those currently available will increase the choice in AIDS prevention and spread by women and reduce the number of HIV infections. infections», He insists in the press release.
“As with the Covid-19 vaccine, we now need to ensure that these life-saving injections are available, affordable and equally distributed to the people who will use them.», A soul mate Winnie Byanyima.
SEE ALSO – The researchers succeeded in eliminating the AIDS virus in mice
.
[ad_2]
Source link
